Clinical Trial Update: A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial protocol update for 1% OPA-15406 foam versus vehicle in adult Atopic Dermatitis; not yet recruiting. The study is sponsored by Otsuka Pharmaceutic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• OPA-15406 Foam (OPA-15406)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Atopic Dermatitis (AD) | Phase 3 | Status: NOT_YET_RECRUITING